NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Qurate Retail Group, Inc., OPKO Health, Inc., and Cocrystal Pharma, Inc. Stockholders have until the deadlines listed below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Qurate Retail Group, Inc. (NASDAQ: QRTEA)
Class Period: August 5, 2015 - September 7, 2016
Lead Plaintiff Deadline: November 5, 2018
The complaint alleges that throughout the Class Period, defendants’ statements pertaining to the company’s revenue growth were materially false and misleading because defendants failed to disclose that: (1) the company was aggressively loosening the credit standards of its Easy-Pay program to attract a large group of new customers; (2) the company’s strong sales growth was due to this loose credit policy; (3) accounts receivable associated with this new group of customers posed a high risk of write-off; and (4) as a result of the foregoing, the company’s positive statements about its business, operations, and prospects lacked a reasonable basis.
To learn more about the Qurate class action go to: http://bespc.com/qurate/.
OPKO Health, Inc. (NASDAQ: OPK)
Class Period: September 26, 2013 - September 7, 2018
Lead Plaintiff Deadline: November 13, 2018
The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) OPKO and its Chairman and Chief Executive Officer, Phillip Frost, were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) this illicit scheme would result in governmental scrutiny including from the SEC; and (3) as a result, defendants’ statements about OPKO’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the OPKO class action go to: http://bespc.com/opk/.
Cocrystal Pharma, Inc. (NASDAQ: COCP)
Class Period: September 23, 2013 - September 7, 2018
Lead Plaintiff Deadline: November 18, 2018
The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) defendants were engaged in a pump-and-dump scheme to artificially inflate Cocrystal’s stock price; (2) this illicit scheme would result in governmental scrutiny, including from the SEC; (3) defendants failed to abide by SEC disclosure regulations; and (4) as a result, defendants’ statements about Cocrystal’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more about the Cocrystal class action go to: https://bespc.com/cocrystal/.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com